Discover the advanced imaging capabilities at the Fralin Biomedical Research Institute at VTC, part of Virginia Tech (Roanoke, VA, USA), where cancer scientists are revolutionizing preclinical research with the help of Bruker's cutting-edge technology. The institute’s small animal imaging core features the simultaneous PET/MRI (BioSpec 94/20 + PET Insert Si 103) and PET/CT Si78, enabling researchers to monitor brain and cardiovascular dynamics with exceptional spatial and temporal resolution, non-invasively and over time.
Through insights from Michael Friedlander, Ph.D, Jenny Munson, Ph.D, and core manager Maosen Wang, Ph.D, learn how these instruments accelerate translational research, streamline multimodal workflows, and unlock new possibilities for personalized therapies and drug development.
Bruker offers advanced preclinical imaging solutions for a broad spectrum of application fields, such as oncology, neurology, cardiology, inflammation, infectious diseases, cancer research, functional and anatomical neuroimaging, orthopedics, cardiac imaging and stroke models.